Volume 38, Issue 5 pp. 747-751
Experimental Cancer
Full Access

Oligoclonal tumours

M. F. A. Woodruff

M. F. A. Woodruff

Medical Research Council Clinical and Population Cytogenetics Unit, Western General Hospital, Crewe Road, Edinburgh EH4 2XU

Department of Zoology, University of Edinburgh, The King's Buildings, West Matins Road, Edinburgh EH9 3JT, Scotland

Department of Applied Mathematics, University of Adelaide, South Australia 5001

Search for more papers by this author
J. D. Ansell

J. D. Ansell

Medical Research Council Clinical and Population Cytogenetics Unit, Western General Hospital, Crewe Road, Edinburgh EH4 2XU

Department of Zoology, University of Edinburgh, The King's Buildings, West Matins Road, Edinburgh EH9 3JT, Scotland

Department of Applied Mathematics, University of Adelaide, South Australia 5001

Search for more papers by this author
B. A. Hodson

B. A. Hodson

Medical Research Council Clinical and Population Cytogenetics Unit, Western General Hospital, Crewe Road, Edinburgh EH4 2XU

Department of Zoology, University of Edinburgh, The King's Buildings, West Matins Road, Edinburgh EH9 3JT, Scotland

Department of Applied Mathematics, University of Adelaide, South Australia 5001

Search for more papers by this author
R. B. Potts

R. B. Potts

Medical Research Council Clinical and Population Cytogenetics Unit, Western General Hospital, Crewe Road, Edinburgh EH4 2XU

Department of Zoology, University of Edinburgh, The King's Buildings, West Matins Road, Edinburgh EH9 3JT, Scotland

Department of Applied Mathematics, University of Adelaide, South Australia 5001

Search for more papers by this author
First published: 15 November 1986
Citations: 2

Abstract

Tumours are commonly classified as monoclonal or polyclonal. The question of how many clones are present in a polyclonal tumour is seldom asked; it is important, however, because the answer may show whether or not clones arise and develop independently, and whether the number of clones in tumours of a particular kind tends to increase or decrease with time. We have used two procedures to assess the clon-ality of chemically-induced murine fibrosarcomas, one based on the heterozygosity of the tumour hosts for an X-linked marker, the other on the expression of tumour-associated transplantation antigens (TATA) by the tumours. As we have reported previously, many of these tumours are pleoclonal. Evidence now presented suggests that the clones do not develop independently and that many of the tumours are biclonal.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.